scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Tiziana Meschi | Q56426899 |
Daniele Del Rio | Q38801742 | ||
Fulvio Lauretani | Q43120816 | ||
Antonio Nouvenne | Q47323585 | ||
P2093 | author name string | Andrea Ticinesi | |
Christian Milani | |||
Marco Ventura | |||
Marcello Maggio | |||
Claudio Tana | |||
P2860 | cites work | Does nutrition play a role in the prevention and management of sarcopenia? | Q47776645 |
Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material Properties | Q48187011 | ||
Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice | Q48325676 | ||
The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. | Q48343525 | ||
Intramuscular Fat Infiltration Contributes to Impaired Muscle Function in COPD. | Q53252164 | ||
Identification and treatment of older persons with sarcopenia | Q58136346 | ||
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics | Q87909855 | ||
Feeding the microbiota: transducer of nutrient signals for the host | Q38664872 | ||
The human gut microbiome in health: establishment and resilience of microbiota over a lifetime | Q38802303 | ||
Systematic Literature Review on the Relationship Between Biomarkers of Sarcopenia and Quality of Life in Older People | Q38844135 | ||
A gut reaction: the combined influence of exercise and diet on gastrointestinal microbiota in rats | Q38918855 | ||
"Brain-muscle loop" in the fragility of older persons: from pathophysiology to new organizing models | Q38944732 | ||
Signals from the gut microbiota to distant organs in physiology and disease | Q38973619 | ||
Nutrition and the gut microbiome in the elderly. | Q38997378 | ||
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics | Q39065664 | ||
Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies | Q39069842 | ||
Gut microbiota: A player in aging and a target for anti-aging intervention | Q39097545 | ||
"Nutraceuticals" in relation to human skeletal muscle and exercise | Q39112416 | ||
Sarcopenia: an overview. | Q39117131 | ||
Measurement of muscle mass in sarcopenia: from imaging to biochemical markers | Q39125530 | ||
Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis | Q39127475 | ||
Physical activity and exercise as countermeasures to physical frailty and sarcopenia. | Q39127874 | ||
Muscle Ultrasound and Sarcopenia in Older Individuals: A Clinical Perspective | Q39137186 | ||
Gut Microbiota and Extreme Longevity | Q39761648 | ||
Mediterranean diet and faecal microbiota: a transversal study | Q39802329 | ||
Age-related Changes in Energy Intake and Weight in Community-dwelling Middle-aged and Elderly Japanese | Q39901948 | ||
The incidence of sarcopenia among hospitalized older patients: results from the Glisten study | Q40039365 | ||
Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study. | Q40280146 | ||
The human gut microbiota and its interactive connections to diet. | Q40681445 | ||
Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients | Q41328388 | ||
Moderate-Intensity Exercise Affects Gut Microbiome Composition and Influences Cardiac Function in Myocardial Infarction Mice | Q41619531 | ||
Comparison of Diet versus Exercise on Metabolic Function and Gut Microbiota in Obese Rats. | Q41738731 | ||
Role and potential mechanisms of anabolic resistance in sarcopenia | Q41955962 | ||
A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. | Q42998684 | ||
The normal colonic bacterial flora | Q43248773 | ||
Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population. | Q43364575 | ||
Sarcopenia and malnutrition in acutely ill hospitalized elderly: Prevalence and outcomes | Q43640071 | ||
A review of the relationship between the gut microbiota and amino acid metabolism. | Q46303633 | ||
The Gut Metagenome Changes in Parallel to Waist Circumference, Brain Iron Deposition, and Cognitive Function | Q46354626 | ||
Biological Aging and the Human Gut Microbiota | Q46376615 | ||
Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. | Q46390377 | ||
Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial. | Q46543416 | ||
Enterotypes of the human gut microbiome | Q24489818 | ||
Human gut microbiome viewed across age and geography | Q24602950 | ||
Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People | Q24633789 | ||
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice | Q24676006 | ||
Nutrition and Inflammation in Older Individuals: Focus on Vitamin D, n-3 Polyunsaturated Fatty Acids and Whey Proteins | Q26752590 | ||
Gut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health? | Q26765902 | ||
Anorexia of Aging: Risk Factors, Consequences, and Potential Treatments | Q26772927 | ||
Biomarkers for physical frailty and sarcopenia: state of the science and future developments | Q26775328 | ||
The gut microbiota and host health: a new clinical frontier | Q26785649 | ||
Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases | Q27002456 | ||
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials | Q27022354 | ||
The Effect of Diet and Exercise on Intestinal Integrity and Microbial Diversity in Mice | Q27319465 | ||
Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor γ and Glucagon-Like Peptide-1 | Q27321785 | ||
Gut Bifidobacteria Populations in Human Health and Aging | Q28071697 | ||
Gut flora in health and disease | Q28209082 | ||
Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling | Q28394742 | ||
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome | Q28645773 | ||
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns | Q29547261 | ||
Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
The human microbiome: at the interface of health and disease | Q29614801 | ||
Gut microbiota composition correlates with diet and health in the elderly | Q29617441 | ||
Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. | Q30235498 | ||
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity | Q36002388 | ||
Diet-microbiota interactions as moderators of human metabolism | Q36069065 | ||
The Central Nervous System and the Gut Microbiome. | Q36182979 | ||
Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease | Q36201694 | ||
Adherence to a Mediterranean Diet Influences the Fecal Metabolic Profile of Microbial-Derived Phenolics in a Spanish Cohort of Middle-Age and Older People. | Q36234360 | ||
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis | Q36251208 | ||
Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS). | Q36258760 | ||
Differences in gut microbiota profile between women with active lifestyle and sedentary women. | Q36277135 | ||
The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging | Q36410021 | ||
Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults | Q36618081 | ||
Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study | Q36889936 | ||
Beneficial bacteria inhibit cachexia | Q37022010 | ||
Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial. | Q37050763 | ||
Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions | Q37157802 | ||
Muscle Quality and Myosteatosis: Novel Associations With Mortality Risk: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study | Q37220560 | ||
IGF-1, the cross road of the nutritional, inflammatory and hormonal pathways to frailty | Q37286765 | ||
Functional metagenomic profiling of intestinal microbiome in extreme ageing | Q37445053 | ||
Gut microbiota induce IGF-1 and promote bone formation and growth | Q37451310 | ||
Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm | Q37670867 | ||
The impact of ageing, physical activity, and pre-frailty on skeletal muscle phenotype, mitochondrial content, and intramyocellular lipids in men. | Q37734812 | ||
Exercise and Protein Intake: A Synergistic Approach against Sarcopenia | Q37736400 | ||
Butyrate: implications for intestinal function | Q38026458 | ||
Bacteria as vitamin suppliers to their host: a gut microbiota perspective | Q38039782 | ||
The role of malnutrition in older persons with mobility limitations. | Q38139486 | ||
Exercise as a remedy for sarcopenia. | Q38169061 | ||
The SCFA Receptor GPR43 and Energy Metabolism | Q38219970 | ||
Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice | Q38598113 | ||
Unraveling the gut microbiome of the long-lived naked mole-rat | Q38602984 | ||
Moderate Exercise Has Limited but Distinguishable Effects on the Mouse Microbiome | Q38606166 | ||
Indoles from commensal bacteria extend healthspan. | Q38615476 | ||
Community characteristics of the gut microbiomes of competitive cyclists | Q38630152 | ||
The Association between Cardiorespiratory Fitness and Gut Microbiota Composition in Premenopausal Women. | Q38652698 | ||
Composition, variability, and temporal stability of the intestinal microbiota of the elderly | Q30499047 | ||
Role of Gut Microbiota and Short Chain Fatty Acids in Modulating Energy Harvest and Fat Partitioning in Youth. | Q31131918 | ||
Microbial diversity in the human intestine and novel insights from metagenomics | Q33416331 | ||
Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians | Q33586253 | ||
Dominant and diet-responsive groups of bacteria within the human colonic microbiota | Q33649520 | ||
The Crosstalk between the Gut Microbiota and Mitochondria during Exercise | Q33705451 | ||
Betaine promotes cell differentiation of human osteoblasts in primary culture. | Q33776500 | ||
Maternal inheritance of bifidobacterial communities and bifidophages in infants through vertical transmission | Q33837496 | ||
Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota? | Q33852208 | ||
Frailty in elderly people | Q33902569 | ||
Microbes in gastrointestinal health and disease | Q33943525 | ||
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. | Q34006689 | ||
The first 1000 cultured species of the human gastrointestinal microbiota. | Q34041082 | ||
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases | Q34145591 | ||
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism | Q34355154 | ||
Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group | Q34401526 | ||
Dietary intake, dietary patterns, and changes with age: an epidemiological perspective | Q34454663 | ||
Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents | Q34533772 | ||
Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. | Q34591010 | ||
Exercise, oxidative stress and hormesis | Q34687654 | ||
Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol | Q34837950 | ||
Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. | Q35020145 | ||
Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity | Q35132021 | ||
Exercise and associated dietary extremes impact on gut microbial diversity | Q35206523 | ||
Exercise is More Effective at Altering Gut Microbial Composition and Producing Stable Changes in Lean Mass in Juvenile versus Adult Male F344 Rats | Q35643176 | ||
Composition and temporal stability of the gut microbiota in older persons | Q35668612 | ||
Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk | Q35685937 | ||
The aromatic amino acid tryptophan stimulates skeletal muscle IGF1/p70s6k/mTor signaling in vivo and the expression of myogenic genes in vitro | Q35733411 | ||
High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome | Q35791181 | ||
Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). | Q35873043 | ||
Signatures of early frailty in the gut microbiota | Q35907894 | ||
Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children | Q35935211 | ||
Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle | Q35986664 | ||
High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity | Q35999905 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P921 | main subject | frailty syndrome | Q177171 |
human ageing | Q332154 | ||
human gut flora | Q739734 | ||
skeletal striated muscle | Q1048687 | ||
sarcopenia | Q1787939 | ||
nutritional status | Q67151937 | ||
P577 | publication date | 2017-11-30 | |
P1433 | published in | Nutrients | Q7070485 |
P1476 | title | Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis? | |
P478 | volume | 9 |
Q93054978 | A Review of the Role of the Gut Microbiome in Personalized Sports Nutrition |
Q91761374 | Allicin Improves Metabolism in High-Fat Diet-Induced Obese Mice by Modulating the Gut Microbiota |
Q90699673 | Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty |
Q99550455 | Diet and gut microbiome interactions in gynecologic cancer |
Q57175283 | Dietary Protein and Muscle in Aging People: The Potential Role of the Gut Microbiome |
Q64945369 | Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial. |
Q92826858 | Efficacy of Nutritional Interventions as Stand-Alone or Synergistic Treatments with Exercise for the Management of Sarcopenia |
Q92326187 | Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study |
Q93164494 | Gut Microbiota and Microbiota-Related Metabolites as Possible Biomarkers of Cognitive Aging |
Q91994628 | Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia |
Q59330596 | Gut microbiota in common elderly diseases affecting activities of daily living |
Q58694401 | Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review |
Q89879968 | Gut-Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis |
Q93003274 | Impact of Melatonin on Skeletal Muscle and Exercise |
Q92538128 | Lifestyle-Induced Microbial Gradients: An Indian Perspective |
Q57286342 | Marriage and Gut (Microbiome) Feelings: Tracing Novel Dyadic Pathways to Accelerated Aging |
Q57929730 | Metronidazole Causes Skeletal Muscle Atrophy and Modulates Muscle Chronometabolism |
Q55023794 | Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism. |
Q58773148 | Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease |
Q89683150 | Nutritional Status as a Mediator of Fatigue and Its Underlying Mechanisms in Older People |
Q92757948 | Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles |
Q61806704 | PS23 decelerated age-related muscle loss by ensuring mitochondrial function in SAMP8 mice |
Q94544639 | Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables |
Q93109023 | Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation |
Q58773316 | Royal Jelly Delays Motor Functional Impairment During Aging in Genetically Heterogeneous Male Mice |
Q55022891 | Sarcopenia: assessment of disease burden and strategies to improve outcomes. |
Q97643860 | Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function |
Q92494610 | Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome |
Q94493569 | The Gut Microbiome and Frailty |
Q58611705 | The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis |
Q64903090 | The impact of intestinal microbiota on bio-medical research: definitions, techniques and physiology of a "new frontier". |
Q64864435 | Uric Acid and Cognitive Function in Older Individuals |
Search more.